文章名稱引用次數

• Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018393
• Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update57
• Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1. irRECIST and iRECIST criteria57
• Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease49
• Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort49
• Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer43
• Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort42
• Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task41
• General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 386 persons across 13 European countries, Canada and the Unites States41
• Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial39